Transdermal Drug Delivery Market To Surpass USD 40 Billion By 2018

The major factor driving such a significant growth in the market is the increasing number of transdermal drug delivery products introduced into the market.

Release Date: 05-May-2014



Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through the layers of the skin and into the bloodstream. This patch is considered to be a self contained, discrete dosage form, when applied to the intact skin, would deliver the drug, through the skin at a controlled rate to the systemic circulation.

There has been a significant upward trend in the global market for transdermal drug delivery. The market for transdermal drug delivery was worth US$ 25 billion in 2013 and is further anticipated to surpass US$ 40 billion by 2018. The major factor driving such a significant growth in the market is the increasing number of transdermal drug delivery products introduced into the market and continuously delivering therapeutic benefits in the real sense to the patients across the globe.

 

“Transdermal Drug Delivery Market Opportunity & Clinical Pipeline Insight” Report Highlights:

 

 

For More Information Visit: Transdermal Drug Delivery Market Opportunity & Clinical Pipeline Insight

Need custom market research solution? We can help you with that too.